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ABSTRACT: Climate change necessitates the development of
CO2 neutral or negative routes to chemicals currently produced
from fossil carbon. In this paper we demonstrate a pathway from
the renewable resource glucose to next generation biofuel
isopentanol by pairing the isovaleryl-CoA biosynthesis pathway
from Myxococcus xanthus and a butyryl-CoA reductase from
Clostridium acetobutylicum. The best plasmid and Escherichia coli
strain combination makes 80.50 ± 8.08 (SD) mg/L of isopentanol after 36 h under microaerobic conditions with an oleyl alcohol
overlay. In addition, the system also shows a strong preference for isopentanol production over prenol in microaerobic conditions.
Finally, the pathway requires zero adenosine triphosphate and can be paired theoretically with nonoxidative glycolysis, the
combination being redox balanced from glucose thus avoiding unnecessary carbon loss as CO2. These pathway properties make the
isovaleryl-CoA pathway an attractive isopentanol production route for further optimization.
KEYWORDS: isopentanol, isovaleryl-CoA pathway, biofuel
Anthropogenic climate change represents a signiﬁcantchallenge for modern society, with transportation
activities and petrochemical production contributing about 7
gigatonnes of CO2 equivalents annually.
1 Sugar-derived
biofuels and bioproducts oﬀer an alternate source of these
necessary molecules at lower CO2 emissions.
2 First generation
biofuels, ethanol and biodiesel, have drawbacks compared to
fossil fuels in internal combustion engines, necessitating the
development of newer and better molecules that can be
derived from renewable sources.3−5 Five-carbon alcohols have
better fuel properties for internal combustion engines than
ethanol as they have a higher blending limit with gasoline, are
less hygroscopic, and have a higher energy density.
Two main pathways for ﬁve-carbon alcohol production have
received considerable attention in the past, namely the
mevalonate pathway to isoprenol (Supporting Information,
Sup. Figure 1A),6−8 and the leucine pathway to isopentanol
(Sup. Figure 1C).9 The mevalonate pathway requires three
adenosine triphosphate (ATP), three acetyl-CoA, and two
NAD(P)H molecules to make isopentenyl pyrophosphate
(IPP). The pyrophosphate is then removed by two successive
phosphatases yielding isoprenol. Recently a variant of this
pathway has been developed that saves one ATP per isoprenol
produced (Sup. Figure 1B).10 The pathway uses a mutated
mevalonate pyrophosphate decarboxylase to accept mevalonate
phosphate instead of mevalonate pyrophosphate. Thus, one
ATP is used to make mevalonate phosphate, and one ATP is
used to decarboxylate that intermediate to isopentenyl
phosphate. The isopentenyl phosphate can then be dephos-
phorylated to isoprenol.
Another route to a branched ﬁve-carbon alcohol is through
leucine biosynthesis to isopentanol (Sup. Figure 1C).11 The
pathway starts with two pyruvates making 2-acetolactate via a
decarboxylation. After several steps, including a condensation
with acetyl-CoA, the pathway yields 4-methyl-2-oxopenta-
noate, the direct precursor of leucine. Decarboxylation of 4-
methyl-2-oxopentanoate makes 3-methylbutanal, which can
then be reduced to 3-methylbutanol, more commonly known
as isopentanol. This eight-step pathway uses no ATP, but does
require the oxygen sensitive IlvD enzyme.12
At ﬁrst glance the leucine pathway appears more eﬃcient
from an ATP standpoint and equal from a carbon standpoint
compared to the mevalonate route. However, pairing the
mevalonate based pathway with nonoxidative glycolysis13
makes the combination more carbon eﬃcient than the leucine
pathway (Table 1). Nonoxidative glycolysis converts glucose
into three acetyl-phosphates which can then be converted to
three acetyl-CoAs without any CO2 loss, and has been
demonstrated in vitro and in vivo.14,15 Because the mevalonate
pathway uses acetyl-CoA exclusively, it is possible to use
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nonoxidative glycolysis to redox balance isoprenol production.
The leucine pathway on the other hand cannot be redox
balanced from glucose using nonoxidative glycolysis because it
requires two pyruvate and one acetyl-CoA (Table 1). Even
when the acetyl-CoA is produced via nonoxidative glycolysis
the production of each isopentanol yields an extra reducing
equivalent.
As biofuels and commodity chemicals have low margins, an
optimal pathway for ﬁve carbon alcohols would combine the
beneﬁts of the leucine pathway and the mevalonate pathway.
Mainly a pathway that is both ATP positive and redox
balanced thus enabling microaerobic or anaerobic growth
conditions. Here we demonstrate a pathway that can produce
isopentanol based on the Myxococcus xanthus pathway to
isovaleryl-CoA.
M. xanthus has previously been noted to produce isovaleryl-
CoA for fatty acid biosynthesis in an unusual way.16 It uses the
ﬁrst two steps of the mevalonate pathway to make HMG-CoA,
and then uses a dehydratase to make 3-methylglutaconyl-CoA
(Figure 1). This is then decarboxylated to make 3-
methylbutenoyl-CoA which can be reduced to isovaleryl-
CoA, a fatty acid biosynthesis starter unit. In our work here, we
couple this pathway to a butyryl-CoA reductase from
Clostridium acetobutylicum to make isopentanol.
■ MODELING
To conﬁrm the thermodynamic viability of the pathway we
used the modeling software eQuilibrator.17 We modeled the
worst-case scenario for which the thiolase and HMG-CoA
synthase do not have substrate channeling as is possible in
certain conﬁgurations.18 The modeling shows the pathway to
be thermodynamically feasible, with glycolysis having the
lowest min-max driving force (MDF) section of the pathway,
and therefore expected to be limiting from a thermodynamic
perspective (Figure 2).
■ EXPERIMENTAL RESULTS
Given the promising modeling results, we constructed several
plasmids to test the pathway’s viability in vivo. We used the
p15A origin, chloramphenicol resistance marker, lacI and
IPTG-inducible PLacUV5-driven operon containing the native
sequence of the Escherichia coli thiolase atoB and the native
sequence of Staphylococcus aureus HMGS from the plasmid
MevTsa-T1002-Ptrc-MKco-PMKco (JPUB_006224) for the
expression of the upper portion of the pathway.7 We based our
designs oﬀ this plasmid because it showed high IPP ﬂux
previously, and the ﬁrst two genes are common to our
pathway. PTrc drives the lower portion of the pathway
containing adhE2 from Clostridium acetobutylicum19 as the
isovaleryl-CoA reductive thioesterase (native substrate butyryl-
CoA), followed by aibC, which encodes the 3-methyl-2-
Table 1. The upper portion of the table shows the
stoichiometry of diﬀerent pathways to C5 alcohols from
glucose using only glycolysis. The lower portion of the table
shows the stoichiometry of diﬀerent pathways to make C5
alcohols from glucose balancing glycolysis and nonoxidative
glycolysis (NOG) to make the complete pathway as redox
balanced as theoretically possible. The mevalonate pathway
is abbreviated as MEV.
glycolysis
before input output
net ATP
per
glucose
redox
balanced
isovaleryl-
CoA
pathway
3 glucose 2 isopentanol + 6 ATP +
6 Nad(P)H + 8 CO2
2 no
MEV
pathway
3 glucose 2 isoprenol + 0 ATP + 8
Nad(P)H + 8 CO2
0 no
MEV bypass
pathway
3 glucose 2 isoprenol + 2 ATP + 8
Nad(P)H + 8 CO2
2/3 no
leucine
pathway
3 glucose 2 isopentanol + 6 ATP +
6 Nad(P)H + 8 CO2
2 no
glycolysis
balanced with
NOG before input output
net ATP
per
glucose
redox
balanced
isovaleryl-
CoA
pathway
5 glucose 4 isopentanol + 6 ATP
+ 10 CO2 + 6 H2O
6/5 yes
MEV pathway 7 glucose 6 isoprenol − 12 ATP
+ 12 CO2 + 12 H2O
− 12/7 yes
MEV bypass
pathway
7 glucose 6 isoprenol − 6 ATP +
12 CO2 + 12 H2O
− 6/7 yes
leucine
pathway
4 glucose 3 isopentanol + 6 ATP
+ 9 CO2 + 3
Nad(P)H + 3 H2O
3/2 no
Figure 1. Overview of the isovaleryl-CoA pathway to isopentanol. (A) First two steps of the mevalonate pathway. (B) Isovaleryl-CoA biosynthesis
pathway. (C) Final reaction to produce isopentanol requiring an enzyme to catalyze a non-native reaction. (D) Plasmid map schematic for plasmids
pII3,5,6,7,8,15. Enzyme abbreviations/natural activity: [HMGS, 3-hydroxy-3-methylglutaryl-coenzyme A synthase]; [LiuC, 3-hydroxy-3-
methylglutaryl-coenzyme A dehydratase]; [AibA/B, 3-methylglutaconyl-coenzyme decarboxylase]; [AibC, 3-methylbutenoyl-coenzyme A
reductase]; [AdhE2, butyryl-coenzyme A reductase].
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butenyl-CoA reductase,16 followed by liuC from Pseudomonas
putida,20 which encodes the 3-methylglutaconyl-CoA dehy-
dratase, followed by the genes encoding the two halves of the
heterodimer 3-methylglutaconyl-CoA decarboxylase, aibA and
aibB.16 Except when noted above, the amino acid sequences
were derived from Myxococcus xanthus. All the genes in the
PTrc-driven operon were codon optimized for E. coli expression
with BOOST (https://boost.jgi.doe.gov/).21 We named this
plasmid pII3.
We transformed pII3 into E. coli DH1,22 and expressed the
genes as previously reported for C5 alcohol production with
minor modiﬁcations.10 pII3 only made trace isopentanol, but
made prenol instead at 56.73 ± 5.45 mg/L 24 h after induction
in aerobic conditions, and 11.3 ± 2.64 mg/L in microaerobic
conditions (Figure 3). We hypothesized that AibC was not
expressed at a high enough level to make signiﬁcant amounts
of isovaleryl-CoA and thus isopentanol. To troubleshoot we
replaced the M. xanthus gene with several diﬀerent aibC
homologues codon optimized to express in E. coli behind a new
RBS predicted to be stronger by the RBS calculator.23 The
aibC homologues in pII5 through pII7 are from Cystobacter
fuscus, Myxococcus fulvus, and Myxococcus stipitatus, respec-
tively. These genes were found using BLAST24 and selected for
testing based on their relatively high amino acid sequence
identity with AibC from M. xanthus indicating they likely
catalyze the desired reaction. aibC in pII8 is an alternately
codon optimized gene from M. xanthus as compared to pII3.
Several of these new plasmids were able to produce
isopentanol. pII5 produced the most isopentanol at 10.88 ±
1.15 mg/L 24 h after induction aerobically (Figure 3A) but
also produced signiﬁcant prenol at 24.07 ± 2.26 mg/L as well
(Figure 3B). Microaerobic prenol production for pII5 was
greatly reduced to 3.46 ± 0.3 mg/L while isopentanol
production was increased to 17.59 ± 0.3 mg/L for a selectivity
of approximately 5 to 1 isopentanol to prenol (Figure 3).
On the basis of these results we designed a plasmid to
increase isopentanol titers and named it pII15. We replaced the
origin of replication and resistance marker of pII5 with a high
copy number origin of replication, ColE1, and an AmpR
resistance marker from plasmid pJH20 (JPUB_011968).26
Using the same production and analysis pipeline as before,
pII15 produced 20.44 ± 1.82 mg/L isopentanol and 56.26 ±
12.41 mg/L prenol aerobically. The microaerobic condition
produced 37.44 ± 4.73 mg/L isopentanol and only 0.66 ± 0.57
mg/L prenol (Figure 3A,B).
Next, we tried another E. coli strain XX03 to improve
production in microaerobic conditions. XX03 is a BW25113
derivative with knockouts in lactic acid, ethanol, and succinate
fermentation genes (adhEΔ ldhAΔ f rdBCΔ) to reduce
unwanted byproduct formation under microaerobic and
anaerobic conditions. We found the pII15 XX03 combination
further bolstered isopentanol production to 63.95 ± 2.26 mg/
L while maintaining low prenol production, 1.07 ± 0.23 mg/L
(Figure 3C).
Finally, with this best strain and plasmid combination we
added an oleyl alcohol overlay and took a time course over 36
h, measuring isopentanol, OD600, glucose, and organic acids
production (Figure 4). At the 36 h time point the cells had
produced 80.50 ± 8.08 mg/L isopentanol, while prenol
Figure 2. Thermodynamic modeling of the isopentanol production
via the isovaleryl-CoA pathway. Metabolites were allowed to vary
from 1 μM to 10 mM at pH 7.0 and ionic strength at 0.1 M for the
MDF-optimization (default conditions). The predicted bottleneck
reactions from a thermodynamic perspective are in glycolysis between
the fructose diphosphate aldolase to glyceraldehyde phosphate
dehydrogenase reactions.
Figure 3. C5 alcohol production 24 h after induction. Plasmids were tested in either E. coli DH1 cell line or XX03 (BW25113 adhEΔ ldhAΔ
f rdBCΔ) in aerobic (200 rpm shaking), or microaerobic (no shaking) conditions in EZ-rich media. pBbA1c-RFP and pBbE1a-RFP are negative
control plasmids which express RFP.25 Error bars represent standard deviation of biological triplicates except for DH1 pII15 and XX03 pII15 in
panel C which represent eight biological replicates. (A) Isopentanol production in DH1. (B) Prenol production coproduced from the same cell
cultures as in panel A. (C) Microaerobic production of isopentanol and prenol in E. coli strains DH1 and XX03. The aibC gene origin in the
diﬀerent plasmids are as follows: pII3 M. xanthus, pII5 Cystobacter fuscus, pII6 Myxococcus fulvus, pII7 Myxococcus stipitatus, pII8 M. xanthus
alternate codon optimization, pII15 Cystobacter fuscus.
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production was below the limit of quantiﬁcation. The cells also
produced a signiﬁcant amount of acetate, up to 1.46 ± 0.05 g/
L. The cells did not fully consume the glucose over this time,
meaning that signiﬁcant improvements can still be made to the
system.
■ DISCUSSION
In this work we demonstrated a new isopentanol production
pathway inspired by the isovaleryl-CoA pathway from
Myxococcus xanthus. The pathway requires no ATP and uses
the central carbon metabolite acetyl-CoA for C5 alcohol
production. A similar pathway was published recently that
exclusively makes prenol for incorporation into DMAPP for
higher isoprenoid production but was not demonstrated to
make isopentanol.27 Our best construct and strain combina-
tion, pII15 and XX03, had a 59-fold preference for isopentanol
production over the side product prenol in microaerobic
conditions (without the oleyl alcohol overlay). The preference
for isopentanol over prenol in microaerobic conditions may be
related to the NadH/Nad+ balance of the cell. In aerobic
conditions, the cell can regenerate NadH into Nad+ using
oxygen, via the electron transport chain. In microaerobic and
anaerobic conditions, the cell has a harder time regenerating
Nad+, resulting in a higher NadH to Nad+ balance. It is
possible this change in redox potential of the cell drives
production of isopentanol over prenol in microaerobic
conditions.28
When designing the pathway, two enzyme types were
available for the 3-HMG-CoA dehydratases (LiuC) step.20 The
Myxococcus xanthus LiuC can hydrate the pathway inter-
mediate 3-methylbutenoyl-CoA to 3-methyl-3-hydroxybutyryl-
CoA, a nonproductive side product.16 LiuC from Pseudomonas
putida uses a diﬀerent reaction mechanism which cannot
hydrate 3-methylbutenoyl-CoA and thus avoids a non-
productive side product. However, 3-methylbutenoyl-CoA
acts as a competitive inhibitor of this LiuC. We used the
LiuC from Pseudomonas putida in the current work because
reduction of 3-methylbutenoyl-CoA to isovaleryl-CoA is very
exothermic. When the pathway is fully optimized hopefully this
property will keep 3-methylbutenoyl-CoA levels very low.
Empirical testing will be needed to validate this design choice
fully.
Because the isovaleryl-CoA to isopentanol pathway derives
carbon from acetyl-CoA, it can be coupled to nonoxidative
glycolysis. In theory by splitting ﬂux between nonoxidative
glycolysis to generate acetyl-CoA, and glycolysis to generate
acetyl-CoA, ATP, and NADH, it is possible to produce
isopentanol in an ATP positive and redox balanced manner
with this pathway. ATP positive and redox balanced pathways
can support anaerobic growth as found in the naturally
occurring ethanol, lactic acid, and mixed acid fermentation
pathways. With the right genomic background lacking alternate
fermentation pathways, it would be possible to leverage growth
coupling and adaptive laboratory evolution to quickly improve
the pathway titer, rate, yield, and tolerance.29 Thus we believe
this pathway is a good choice for further optimization.
■ MATERIALS AND METHODS
Chemicals. Carbenicillin disodium salt, EZ-rich medium,
and LB antibiotic plates were ordered from Teknova.
Chloramphenicol was ordered from MP Biomedicals, Inc.
Restriction enzyme BsaI, DpnI, T4 DNA ligase, isopropyl β-D-
1-thiogalactopyranoside (IPTG), and ElectroMAX DH10B
cells were ordered from Thermo Fisher Scientiﬁc. Molecular
grade bovine serum albumin (BSA) was obtained from New
England BioLabs. Dextrose (anhydrous) and ethyl acetate were
purchased from VWR International. Isoprenol (3-methylbut-3-
en-1-ol) was ordered from Acros Organics. Stellar chemically
competent cells were purchased from Takara Bio USA. LB
(Lennox) and TB powder by Merck KGaA, as well as all other
chemicals, were ordered from Sigma-Aldrich.
In Silico Modeling. Min-max driving force (MDF)
modeling was conducted with the eQuilibrator17 web interface
(http://equilibrator.weizmann.ac.il/pathway/) using the de-
fault parameters for all ﬁelds (minimum substrate concen-
tration = 0.001 mM, maximum substrate concentration 10
mM, pH 7.0, ionic strength 0.1 M). We modeled the
conversion of three glucose to two ﬁve-carbon alcohols (and
resulting NADH, ATP, H2O, and CO2 production). Modeling
ﬁles are included in the Supporting Information.
DNA Construction and Sequencing. Primers were
designed with DeviceEditor,30 and Golden Gate assembly31
was used for assembly. Genes were synthesized by Twist or
IDT. Touchdown PCR32 was used to amplify DNA parts using
iProof DNA polymerase. The PCR reaction cycle consisted of
98 °C for 30 s, followed by 10 cycles of 98 °C for 10 s,
annealing temperature for 15 s, then extension at 72 °C for
22.5 s per kb of DNA. In the ﬁrst 10 cycles the annealing
temperature was reduced by 0.5 °C each round. After the ﬁrst
10 cycles, the basic cycle was repeated for another 25 rounds
but with no further reduction in annealing temperature. A ﬁnal
extension time of 5 min was added to the end of the program,
Figure 4. (A) Time course of microaerobic isopentanol production of E. coli XX03 with pII15 plasmid with oleyl alcohol overlay in EZ-rich media.
Time point zero is when cells were induced. (B) Glucose consumption from the same cultures. (C) Organic acid production from the same
cultures. Error bars represent standard deviation of biological triplicate.
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before the temperature was reduced to 10 °C until the DNA
was used. DNA was then gel puriﬁed from a 0.5% agarose gel
using QIAquick Gel Extraction Kit before further DNA
concentrating with a DNA Clean & Concentrator Kit from
Zymo Research. Salts were then removed via dialysis for 30
min using 0.025 μm VWSP membrane ﬁlters from Millipore.
For assemblies, pieces were mixed in equimolar amounts with
a ﬁnal DNA concentration of the backbone around 33 ng per 5
μL of reaction volume. For Golden Gate assemblies the
reaction cycle was used as follows: 25 cycles of 45 °C for 2
min, followed by 5 min of 16 °C, 1 step of 50 °C for 5 min, 1
step of 80 °C for 5 min and then storage at 10 °C until use.
Assembled plasmids were transformed into Stellar chemically
competent cells, or ElectroMax DH10B cells using the
manufacturer’s instructions. Plasmids were sequenced essen-
tially as previously published33,34 using the DIVA seq pipeline.
Plasmid maps are available at https://public-registry.jbei.org/
folders/434.
DNA Transformation and Cell Culturing. E. coli DH1
was transformed using the KCM method. On day one cells
were picked from colonies or glycerol stock into Lysogeny
Broth (LB) medium and allowed to grow overnight shaking at
200 rpm at 37 °C. On day two cells were back diluted 1:100
into 50 mL of fresh LB and allowed to grow as previously until
OD600 0.4. Cells were then chilled on ice for 20 min before
centrifuging them at 8000 RCF for 8 min. Supernatant was
removed and cells were resuspended in 5 mL of 4 °C TSS
(recipe below). Samples of 100 μL of cells were aliquoted into
0.6 mL Eppendorf tubes and either used immediately or ﬂash
frozen with liquid nitrogen and stored at −80 °C until future
use.
For DNA transformation 1 μL of DNA was added to 100 μL
of cells, and 100 μL of 2× KCM (60 mM KCl, 200 mM CaCl2,
100 mM MgCl2) was added. Cells were incubated on ice for
approximately 20 min, before being heat shocked for 90 s at 42
°C in a water bath. 200 μL of Terriﬁc Broth (TB) was added
and the cells were allowed to recover, without shaking, at 37
°C for an hour before being plated onto plates of the correct
antibiotic. When appropriate, carbenicillin was added at a ﬁnal
concentration of 100 μg/mL, and chloramphenicol 30 μg/mL.
To prepare 100 mL TSS, 10 g of polyethylene glycol
(molecular weight 3350), 5 mL of dimethyl sulfoxide
(DMSO), 2 mL of 1 M MgCl2, were mixed, and LB was
added to 100 mL. The mixture was sterile ﬁltered and stored at
4 °C.
Optical density (OD) measurements were taken with a
Beckman Coulter DU 800 spectrophotometer at 600 nm.
Five-Carbon Alcohol Fermentation Conditions. The
ﬁve-carbon alcohol fermentation conditions were as in a
previous work.10 On day one 10 mL of overnight seed cultures
were grown in LB at 37 °C shaking at 200 rpm. On day two
the overnights were diluted 1 to 100 into 10 mL of EZ-rich
medium with 1% glucose, and allowed to grow as before until
they reached an OD600 between 0.6 and 0.8. Cells were then
induced with a ﬁnal concentration of 1 mM IPTG, and the
temperature was reduced to 30 °C at 200 rpm for aerobic
conditions of 0 rpm for microaerobic conditions. For
conditions with oleyl alcohol overlay, 1 mL of oleyl alcohol
was added at the time of IPTG induction. All media contained
the appropriate antibiotic.
Five-Carbon Alcohol Extraction. Five-carbon alcohol
extraction was conducted essentially as elsewhere.10 Brieﬂy, 1-
butanol was added to a ﬁnal concentration of 30 mg/L as
internal standard in ethyl acetate. Then, 750 μL of cell culture
and 750 μL of the ethyl acetate with 1-butanol were vortexed
in microcentrifuge tubes for 15 min at max speed. Tubes were
then centrifuged in an Eppendorf centrifuge 5424 at max speed
(approximately 21100 RCF) for two minutes. A 500 μL aliquot
of the upper, nonpolar, ethyl acetate layer was then collected in
an amber glass GC vial for analysis.
Five-Carbon Alcohol Extraction of Microaerobic
Cultures with Oleyl Alcohol Overlay. Microaerobic
cultures with oleyl alcohol were vortexed immediately prior
to sampling. A 1.8 mL alliquot of oleyl alcohol and cell culture
mixture were collected at 0 h (when IPTG was added for
induction), 12, 24, and 36 h. The 1.8 mL cell culture/oleyl
alcohol mixture was centrifuged at max speed for two minutes.
Then, 250 μL of the supernatant was diluted into 250 μL of
ethyl acetate (reduces the viscosity for GC-FID injection) with
1-butanol as internal standard as before. Only one sample was
taken from each tube so that tubes were not vortexed multiple
times through the microaerobic fermentation.
Analytical Method for Five-Carbon Alcohol Analysis.
The analysis of ﬁve carbon alcohols was performed essentially
as reported elsewhere8 on a Thermo Scientiﬁc Focus GC-FID
with a DB-WAX column (15 m long, 0.32 mm diameter, 0.25
μm ﬁlm thickness). The carrier pressure was set to a constant
at 300 kPa, and the inlet temperature was 200 °C. The oven
temperature was initially set to 40 °C for 90 s, and then
increased at 15 °C a minute until 110 °C. For samples with
oleyl alcohol, the ﬁnal temperature was 250 °C which was held
for 3 min. Injection volume was one microliter.
Glucose and Fermentation Products Analysis. For
analysis of glucose, acetate, formate, succinate, and lactate, 900
μL of cell culture was centrifuged in an Eppendorf centrifuge
5424 at max speed (approximately 21100 RCF) for 1 min. A
200 μL sample of clariﬁed supernatant was then ﬁltered
through AcroPrep 96 well Omega 10K MWCO ﬁlter plates at
1500 RCF on an Eppendorf 5810 R centrifuge for 15 min.
Samples were analyzed by isocratic elution with 4 mM
sulfuric acid using an HPLC system equipped with an Aminex
HPX-87H column (Bio-Rad, Richmond, CA, USA) and a
refractive index detector (Agilent Technologies). The ﬂow rate
was maintained at 0.6 mL/min, the sample tray was set to 4
°C, and the column compartment temperature was set to 50
°C. Data acquisition and analysis were performed via
Chemstation software (Agilent Technologies).
Data Availability. Plasmid maps are available in the JBEI
public registry (https://public-registry.jbei.org/folders/434).35
Supplemental data is available at the Experiment Data Depot
(EDD) (https://public-edd.jbei.org/s/eiben-et-al-c5-alcohol-
production/overview/).36 See the Supporting Information
data ﬁle for additional information about strain names for
archive requests from corresponding author, Addgene, or
Molecular Cloud.
■ ASSOCIATED CONTENT
*sı Supporting Information
The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acssynbio.9b00402.
Sup. Figure 1; Sup. Figure 2 (PDF)
Data set_S1 table of contents. Data set_S1: Contains
DH1_C5_AlcoholData, eQuilibratorModeling, Supple-
mentalTable1, SupplementalTable2, SupplementalT-
able3, and SupplementalTable4 (XLSX)
ACS Synthetic Biology pubs.acs.org/synthbio Letter
https://dx.doi.org/10.1021/acssynbio.9b00402
ACS Synth. Biol. XXXX, XXX, XXX−XXX
E
■ AUTHOR INFORMATION
Corresponding Author
Jay D. Keasling − Department of Bioengineering, Department of
Chemical & Biomolecular Engineering, and Institute for
Quantitative Biosciences, University of California, Berkeley,
Berkeley, California 94270, United States; Joint BioEnergy
Institute, Emeryville, California 94608, United States; Biological
Systems & Engineering Division, Lawrence Berkeley National
Laboratory, Berkeley, California 94720, United States; Novo
Nordisk Foundation Center for Biosustainability, Technical
University of Denmark, Kogle Alle, Hørsholm DK2970,
Denmark; Center for Synthetic Biochemistry, Institute for
Synthetic Biology, Shenzhen Institutes for Advanced
Technologies, Shenzhen 518055, China; orcid.org/0000-
0003-4170-6088
Authors
Christopher B. Eiben − Department of Bioengineering,
University of California, Berkeley, Berkeley, California 94270,
United States; Department of Bioengineering, University of
California, San Francisco, California 94143, United States
Tian Tian − Joint BioEnergy Institute, Emeryville, California
94608, United States; Biological Systems & Engineering
Division, Lawrence Berkeley National Laboratory, Berkeley,
California 94720, United States
Mitchell G. Thompson − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States; Department of Plant
and Microbial Biology, University of California, Berkeley,
Berkeley, California 94270, United States
Daniel Mendez-Perez − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States
Nurgul Kaplan − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States; Agile BioFoundry,
Emeryville, California 94608, United States
Garima Goyal − Joint BioEnergy Institute, Emeryville, California
94608, United States; Biological Systems & Engineering
Division, Lawrence Berkeley National Laboratory, Berkeley,
California 94720, United States; Agile BioFoundry, Emeryville,
California 94608, United States
Jennifer Chiniquy − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States; Agile BioFoundry,
Emeryville, California 94608, United States
Nathan J. Hillson − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States; Agile BioFoundry,
Emeryville, California 94608, United States; orcid.org/
0000-0002-9169-3978
Taek Soon Lee − Joint BioEnergy Institute, Emeryville,
California 94608, United States; Biological Systems &
Engineering Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, United States; orcid.org/0000-
0002-0764-2626
Complete contact information is available at:
https://pubs.acs.org/10.1021/acssynbio.9b00402
Author Contributions
C.B.E. conceived the project, designed and cloned plasmids,
helped design the experiments and wrote the manuscript. T.T.
designed and cloned plasmids and designed and performed
experiments. M.G.T. and D.M.P. helped with data acquisition
and analysis. N.K. and G.G. performed PCRs for plasmid
construction. J.C. deep sequenced plasmids. N.J.H. edited and
contributed to insights in the manuscript and oversaw plasmid
construction eﬀorts. T.S.L. oversaw T.T. and experiments.
J.D.K. helped write the manuscript and provided project
guidance.
Funding
C.B.E. was supported by National Science Foundation (NSF)
Graduate Research Fellowship Program (DGE-1106400) and
National Institute of Health training Grant T32 GM008295.
NSF Grant 0540879 supported the materials for this work.
This work was part of the DOE Joint BioEnergy Institute
(https://www.jbei.org) supported by the U.S. Department of
Energy, Oﬃce of Science, Oﬃce of Biological and Environ-
mental Research, and was part of the Agile BioFoundry
(https://agilebiofoundry.org) supported by the U.S. Depart-
ment of Energy, Energy Eﬃciency and Renewable Energy,
Bioenergy Technologies Oﬃce, through contract DE-AC02-
05CH11231 between Lawrence Berkeley National Laboratory
and the U.S. Department of Energy. The views and opinions of
the authors expressed herein do not necessarily state or reﬂect
those of the United States Government or any agency thereof.
Neither the United States Government nor any agency thereof,
nor any of their employees, makes any warranty, expressed or
implied, or assumes any legal liability or responsibility for the
accuracy, completeness, or usefulness of any information,
apparatus, product, or process disclosed, or represents that its
use would not infringe privately owned rights. The United
States Government retains and the publisher, by accepting the
article for publication, acknowledges that the United States
Government retains a nonexclusive, paid-up, irrevocable,
worldwide license to publish or reproduce the published
form of this manuscript, or allow others to do so, for United
States Government purposes. The Department of Energy will
provide public access to these results of federally sponsored
research in accordance with the DOE Public Access Plan
(http://energy.gov/downloads/doe-public-access-plan).
Notes
The authors declare the following competing ﬁnancial
interest(s): J.D.K. has a ﬁnancial interest in Amyris, Lygos,
Demetrix, Maple Bio, and Napigen. C.B.E. has a ﬁnancial
interest in Perlumi Chemicals.
■ ACKNOWLEDGMENTS
The authors would like to thank Dr. Xinkai Xie for providing E.
coli strain XX03.
■ REFERENCES
(1) Intergovernmental Panel on Climate Change Working Group
III, and Edenhofer, O. (2014) Climate change 2014: Mitigation of
climate change: Working Group III contribution to the Fifth Assessment
Report of the Intergovernmental Panel on Climate Change, Cambridge
University Press, New York, NY.
(2) Neupane, B., Konda, N. V. S. N. M., Singh, S., Simmons, B. A.,
and Scown, C. D. (2017) Life-Cycle Greenhouse Gas and Water
Intensity of Cellulosic Biofuel Production Using Cholinium Lysinate
Ionic Liquid Pretreatment. ACS Sustainable Chem. Eng. 5, 10176−
10185.
ACS Synthetic Biology pubs.acs.org/synthbio Letter
https://dx.doi.org/10.1021/acssynbio.9b00402
ACS Synth. Biol. XXXX, XXX, XXX−XXX
F
(3) Hansen, A. C., Zhang, Q., and Lyne, P. W. L. (2005) Ethanol-
diesel fuel blends – a review. Bioresour. Technol. 96, 277−285.
(4) Zargar, A., Bailey, C. B., Haushalter, R. W., Eiben, C. B., Katz, L.,
and Keasling, J. D. (2017) Leveraging microbial biosynthetic
pathways for the generation of “drop-in” biofuels. Curr. Opin.
Biotechnol. 45, 156−163.
(5) Haushalter, R. W., Kim, W., Chavkin, T. A., The, L., Garber, M.
E., Nhan, M., Adams, P. D., Petzold, C. J., Katz, L., and Keasling, J. D.
(2014) Production of anteiso-branched fatty acids in Escherichia coli;
next generation biofuels with improved cold-flow properties. Metab.
Eng. 26, 111−118.
(6) George, K. W., Thompson, M. G., Kang, A., Baidoo, E., Wang,
G., Chan, L. J. G., Adams, P. D., Petzold, C. J., Keasling, J. D., and
Lee, T. S. (2015) Metabolic engineering for the high-yield production
of isoprenoid-based C alcohols in E. coli. Sci. Rep. 5, 11128.
(7) George, K. W., Chen, A., Jain, A., Batth, T. S., Baidoo, E. E. K.,
Wang, G., Adams, P. D., Petzold, C. J., Keasling, J. D., and Lee, T. S.
(2014) Correlation analysis of targeted proteins and metabolites to
assess and engineer microbial isopentenol production. Biotechnol.
Bioeng. 111, 1648−1658.
(8) Chou, H. H., and Keasling, J. D. (2012) Synthetic pathway for
production of five-carbon alcohols from isopentenyl diphosphate.
Appl. Environ. Microbiol. 78, 7849−7855.
(9) Atsumi, S., Hanai, T., and Liao, J. C. (2008) Non-fermentative
pathways for synthesis of branched-chain higher alcohols as biofuels.
Nature 451, 86−89.
(10) Kang, A., George, K. W., Wang, G., Baidoo, E., Keasling, J. D.,
and Lee, T. S. (2016) Isopentenyl diphosphate (IPP)-bypass
mevalonate pathways for isopentenol production. Metab. Eng. 34,
25−35.
(11) Gronenberg, L. S., Marcheschi, R. J., and Liao, J. C. (2013)
Next generation biofuel engineering in prokaryotes. Curr. Opin. Chem.
Biol. 17, 462−471.
(12) Flint, D. H., Emptage, M. H., Finnegan, M. G., Fu, W., and
Johnson, M. K. (1993) The role and properties of the iron-sulfur
cluster in Escherichia coli dihydroxy-acid dehydratase. J. Biol. Chem.
268, 14732−14742.
(13) Bogorad, I. W., Lin, T.-S., and Liao, J. C. (2013) Synthetic non-
oxidative glycolysis enables complete carbon conservation. Nature
502, 693−697.
(14) Lin, P. P., Jaeger, A. J., Wu, T.-Y., Xu, S. C., Lee, A. S., Gao, F.,
Chen, P.-W., and Liao, J. C. (2018) Construction and evolution of an
Escherichia coli strain relying on nonoxidative glycolysis for sugar
catabolism. Proc. Natl. Acad. Sci. U. S. A. 115, 3538−3546.
(15) Meadows, A. L., Hawkins, K. M., Tsegaye, Y., Antipov, E., Kim,
Y., Raetz, L., Dahl, R. H., Tai, A., Mahatdejkul-Meadows, T., Xu, L.,
Zhao, L., Dasika, M. S., Murarka, A., Lenihan, J., Eng, D., Leng, J. S.,
Liu, C.-L., Wenger, J. W., Jiang, H., Chao, L., Tsong, A. E., et al.
(2016) Rewriting yeast central carbon metabolism for industrial
isoprenoid production. Nature 537, 694−697.
(16) Li, Y., Luxenburger, E., and Müller, R. (2013) An alternative
isovaleryl CoA biosynthetic pathway involving a previously unknown
3-methylglutaconyl CoA decarboxylase. Angew. Chem., Int. Ed. 52,
1304−1308.
(17) Flamholz, A., Noor, E., Bar-Even, A., and Milo, R. (2012)
eQuilibrator–the biochemical thermodynamics calculator. Nucleic
Acids Res. 40, D770−5.
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